Nargess Arandi

520 total citations
32 papers, 400 citations indexed

About

Nargess Arandi is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Nargess Arandi has authored 32 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 12 papers in Hematology and 5 papers in Oncology. Recurrent topics in Nargess Arandi's work include Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (8 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Nargess Arandi is often cited by papers focused on Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (8 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Nargess Arandi collaborates with scholars based in Iran, Lebanon and Brazil. Nargess Arandi's co-authors include Mani Ramzi, Asghar Aghamohammadi, Hassan Abolhassani, Abbas Mirshafiey, Mahmood Jeddi‐Tehrani, Hossein Golmoghaddam, Babak Mirminachi, Mohammadreza Shaghaghi, Mehdi Dehghani and Ahmad Monabati and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Haematology and European Journal of Neurology.

In The Last Decade

Nargess Arandi

29 papers receiving 395 citations

Peers

Countries citing papers authored by Nargess Arandi

Since Specialization

Citations

This map shows the geographic impact of Nargess Arandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nargess Arandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nargess Arandi more than expected).

Fields of papers citing papers by Nargess Arandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nargess Arandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nargess Arandi. The network helps show where Nargess Arandi may publish in the future.

Co-authorship network of co-authors of Nargess Arandi

This figure shows the co-authorship network connecting the top 25 collaborators of Nargess Arandi. A scholar is included among the top collaborators of Nargess Arandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nargess Arandi. Nargess Arandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High donor regulatory B cells (Bregs) and their rapid recovery are associated with protection from the development of acute graft‐versus‐host disease (aGVHD) following allogeneic hematopoietic stem cell transplantation 2025 ·British Journal of Haematology ·Mani Ramzi, (unknown), Maryam Sanaei, Hossein Golmoghaddam, Mehdi Kalani, Nargess Arandi	0
2	The impact of PD-1/PD-L1, CTLA-4, TIM-3 and LAG-3 immune checkpoint receptor expression in the development of acute graft versus host disease (aGVHD) and disease recurrence after allogeneic hematopoietic stem cell transplantation 2024 ·Human Immunology ·Mani Ramzi, Mehdi Dehghani, (unknown), Hossein Golmoghaddam, Nargess Arandi	1
3	Atopy manifestations in pediatric patients with acute lymphoblastic leukemia: correlation assessment with interleukin-4 (IL-4) and IgE level 2022 ·BMC Pediatrics ·Omid Reza Zekavat, (unknown), Sezaneh Haghpanah, (unknown), (unknown), Nargess Arandi	1
4	The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL) 2021 ·Cancer Immunology Immunotherapy ·Mehdi Dehghani, (unknown), Mani Ramzi, Mehdi Kalani, Hossein Golmoghaddam, Nargess Arandi	14
5	Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype 2021 ·Annals of Hematology ·(unknown), Mehran Karimi, Hossein Golmoghaddam, (unknown), (unknown), Sedigheh Sharifzadeh, Nargess Arandi	0
6	Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma 2020 ·Cancer Immunology Immunotherapy ·Mehdi Dehghani, Mehdi Kalani, Hossein Golmoghaddam, Mani Ramzi, Nargess Arandi	14
7	Genetic Variation of Costimulatory Molecules, Including Cytotoxic T-Lymphocyte Antigen 4, Inducible T-Cell Costimulator, Cluster Differentiation 28, and Programmed Cell Death 1 Genes, in Iranian Patients With Leukemia 2020 ·Experimental and Clinical Transplantation ·Mani Ramzi, Nargess Arandi, (unknown), Ramin Yaghobi, Bita Geramizadeh	6
8	Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia 2019 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), Nargess Arandi, Ramin Yaghobi, Negar Azarpira, Bita Geramizadeh, Mani Ramzi	8
9	Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype 2018 ·Blood Research ·Nargess Arandi, Mani Ramzi, (unknown), Ahmad Monabati	27
10	Mutation of the DNMT3A and IDH1/2 genes in Iranian acute myeloid leukemia patients with normal karyotype (CN-AML): association with other gene mutation and clinical and laboratory characteristics 2018 ·Journal of Hematopathology ·(unknown), (unknown), Mani Ramzi, Nargess Arandi	3
11	FMS-like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia (AML) Patients with Normal Karyotype; Mutation Status and Clinical and Laboratory Characteristics 2017 ·Turkish Journal of Hematology ·(unknown), Nargess Arandi, (unknown), Sezaneh Haghpanah, (unknown), Mani Ramzi	16
12	Association Between Cytotoxic T-Lymphocyte Antigen 4 Gene Polymorphisms and Torque Teno Virus Infection After Hematopoietic Stem Cell Transplantation 2017 ·Experimental and Clinical Transplantation ·Mani Ramzi, (unknown), (unknown), Ramin Yaghobi, Nargess Arandi	7
13	Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients withβ-Thalassemia Intermedia 2015 ·Hemoglobin ·Mehran Karimi, Nargess Arandi, Sezaneh Haghpanah, Shahla Ansari, (unknown), Mohammadreza Bordbar, (unknown)	9
14	Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura. 2014 ·PubMed ·Nargess Arandi, Abbas Mirshafiey, Mahmood Jeddi‐Tehrani, Mohammadreza Shaghaghi, (unknown), Hassan Abolhassani, Ramazan Ali Sharifian, (unknown), Asghar Aghamohammadi	31
15	Polymorphism in Exon 2 of CD1 Genes in Southwest of Iran 2013 ·SHILAP Revista de lepidopterología ·Hossein Golmoghaddam, Nargess Arandi, Abbas Ghaderi	3
16	Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency 2013 ·Cellular Immunology ·Nargess Arandi, Abbas Mirshafiey, Mahmood Jeddi‐Tehrani, Hassan Abolhassani, (unknown), Babak Mirminachi, Mohammadreza Shaghaghi, Asghar Aghamohammadi	45
17	Evaluation of Natural Regulatory T Cells in Subjects with Selective IgA Deficiency: From Senior Idea to Novel Opportunities 2012 ·International Archives of Allergy and Immunology ·Habib Soheili, Hassan Abolhassani, Nargess Arandi, Hossein Ali Khazaei, (unknown), Armin Hirbod‐Mobarakeh, Nima Rezaei, Asghar Aghamohammadi	23
18	Intercellular adhesion molecule-1 genetic markers (+241G/A and +469A/G) in Iranian women with breast cancer 2008 ·Cancer Genetics and Cytogenetics ·Nargess Arandi, Abdolrasoul Talei, Nasrollah Erfani, Abbas Ghaderi	13
19	Intercellular adhesion molecule‐1 gene polymorphism in Iranian patients with multiple sclerosis 2007 ·European Journal of Neurology ·(unknown), (unknown), Nargess Arandi, (unknown), Abbas Ghaderi	5
20	ICAM-1 Polymorphisms (G241R, K469E), in Coronary Artery Disease and Myocardial Infarction 2007 ·PubMed ·(unknown), (unknown), Nargess Arandi	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact